(Sharecast News) - Koninklijke Philips, the Dutch healthcare giant, has finally reached a settlement with US regulators over a Respironics product recall back in 2021 worth $1.1bn, causing shares to soar by more than a third on Monday morning.
The news follows a so-called consent decree agreed earlier this month with...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE